维普期刊资源整合服务平台（V6.5）

122篇 您的检索式：作者名="Richon VM"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Histone deacetylases and cancer: causes and therapies 显示文摘	Marks P Rifkind RA Richon VM	2001	Nat Rev Cancer2001，1，：	1
2	Histone deacetylases and cancer:causes and therapies显示文摘	Marks P Rifkind RA Richon VM	2001	Nat Rre Cancer2001，1，3：	1
3	Cellcycle regulatory protein are target for induced differentiation of transformedcells:molecular and clinic studies employing hybrid polar compounds显示文摘	Marks PA Richon VM Richard A	1996	Int JHematol1996，63，：	1
4	Histone deacetylases and cancer: causes and therapies显示文摘	Marks P Rifkind RA Richon VM	2001	Nat Rev Cancer2001，1，3：	1
5	Histone deacetylases and cancer: causes and therapies显示文摘	Marks P Ritkind RA Richon VM	2001	Nat Rev Cancer2001，1，：	1
6	A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases显示文摘	Richon VM Emiliani S Verdin E	1998	Proc Natl Acad Sci U S A1998，95，6：	1
7	Histone deacetylase inhibitors as new cancer drugs显示文摘	Marks PA Richon VM Breslow R	2001	Curr Opin Oncol2001，13，6：	1
8	Histone deacetylase inhibitors显示文摘	Marks PA Richon VM Miller T	2004	Adv Cancer Res2004，91，1：	1
9	Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells显示文摘	Richon VM Rifkind RA	2000	J Natl Cancer Inst2000，92，15：	1
10	Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoy lanilide hydroxamic acid administered intravenously显示文摘	Kelly WK Richon VM Connor O	2003	Clin Cancer Res2003，9，10：	1
11	Prognostic significance of transcription factor E2F-1 in bladder cancer,genotypic and phenotypic characterization显示文摘	RABBANI F RICHON VM ORLOW I	2012	J Natl Cancer Inst2012，34，9：	1
12	Histone deacetylases and cancer:causes and therapies显示文摘	Marks PA Rifkind RA Richon VM	2001	Nature2001，1，3：	1
13	Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously显示文摘	KELLY WK RICHON VM O'CONNOR O	2003	Clin Cancer Res2003，9，101：	1
14	Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation显示文摘	Richon VM Sandhoff TW Rifkind RA	2000	Proc Natl Acad Sci USA2000，97，10：	1
15	Histone deacetylases显示文摘	Marks PA Miller T Richon VM	2003	Curr Opin Pharmaco12003，3，4：	1
16	Histone deacety-lases and cancer: causes and therapies显示文摘	Marks P Rifkind RA Richon VM	2001	Nat Rev Cancer2001，1，：	1
17	Histone deacetylase in- hibitors as new anticancer drugs显示文摘	Marks PA Richon VM Breslow R	2001	Curr Opin Onco12001，13，：	1
18	Histone deacetylase inhibitors: inducers of differentiation or transformed cells 显示文摘	Marks PA Richon VM Rifkind RA	2000	J Natl Cancer Inst2000，92，15：	1
19	Histone deacetylase inhibitors:a new class of potential therapeutic agents for cancer treatment显示文摘	RICHON VM OBRIEN JP	2002	Clin Cancer Res2002，8，3：	1
20	Histone deacetylase in hibitors显示文摘	Marks PA Richon VM Miller T	2004	Adv Cancer Res2004，91，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示